New diabetes drug shows promise in Mid-Stage trial
NCT ID NCT00497198
Summary
This study tested whether an experimental drug called MCI-196 could help control type 2 diabetes. For 12 weeks, 183 adults with elevated blood sugar took either the drug or a placebo pill, and neither they nor their doctors knew which one. Researchers measured changes in blood sugar and cholesterol levels to see if the treatment was effective and safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.